BAT Science

Quick Navigation

Jump to content Logo
 
Building
A Better
Tomorrow™
Our purpose is to build A Better Tomorrow™ by reducing the health impact of our business through offering a choice of less risky* products for our consumers. Science and innovation are accelerating our Tobacco Harm Reduction mission.
 
Research
We operate in a broad spectrum of scientific fields including molecular biology, toxicology and chemistry, and it is that breadth of expertise which fuels the relentless innovation and learning that sets us apart as an industry leader.
 
Vaccine development
R&D Virtual Visitor Experience
Explore our global Research and Development hub
Publications
  • Bridging: Accelerating Regulatory Acceptance of Reduced-Risk Tobacco and Nicotine Products
    Vapour
    Marianna Gaca
    February 2022
    Bridging: Accelerating Regulatory Acceptance of Reduced-Risk Tobacco and Nicotine Products
  • Pilot study to determine differences in breath odour between cigarette and e-cigarette consumers
    Vapour
    Annette Dalrymple
    February 2022
    Pilot study to determine differences in breath odour between cigarette and e-cigarette consumers
  • Application of ToxTracker for the toxicological assessment of tobacco and nicotine delivery products
    Vapour
    David Smart
    January 2022
    Application of ToxTracker for the toxicological assessment of tobacco and nicotine delivery products

 
Insights
  • Meet our scientists
    Behind the Microscope
    Meet our scientists
  • Take a look at our latest press releases
    News & Features
    Take a look at our latest press releases
  • Find out more about our open and transparent approach
    Science Engagement
    Find out more about our open and transparent approach
  • Dr David O'Reilly shares his thoughts on science, COVID-19, and harm reduction
    Director's View
    Dr David O'Reilly shares his thoughts on science, COVID-19, and harm reduction
  • Explore our Quarterly Science Update
    Report
    Explore our Quarterly Science Update
  • Read our latest Science & Innovation Report
    Report
    Read our latest Science & Innovation Report
/
 
*Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.

Our products as sold in the US, including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.

max
xlarge
large
medium
small
mobile